The largest database of trusted experimental protocols

15 protocols using chromolith performance rp 18e column

1

Purification of Peptide Conjugate 12

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purification of the end product conjugate 12 (Figure 1) was performed by semi-preparative reversed-phase HPLC (Dionex (Idstein, Germany): Ultimate 3000 LPG-3400A pump and variable four wavelength Ultimate 3000 VWD-3400RS UV/VIS detector (222 nm, 254 nm, 280 nm); column: Chromolith Performance RP-18e column (100 × 10 mm; Merck, Darmstadt, Germany). The solvent gradient was raised from 5% to 100% acetonitrile in 5 min at a flow rate of 6 ml/min. The aqueous phase consisted of water containing 0.1% TFA. tR = 3.58 min. The fractions containing the purified peptide were lyophilized. The purified material was characterized with analytical HPLC and matrix assisted laser desorption mass spectrometry. The measured mass: 4138 +5H+ [m/e]. The calculated mass [m/e]: 4133.11 (100.0%); chemical formula C207H273N58O31S2+.
+ Open protocol
+ Expand
2

Quantification of nanoparticle-bound pHPMA and antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amount of pHPMA and antibody attached to the nanoparticles was quantified via amino acid analysis. For the experiment, 4.5 mg of prepared nanoparticles were freeze-dried and subsequently pHPMA and antibody bound to their surface were hydrolyzed (500 μL of 6 M HCl, 18 h, 115 °C in a sealed ampule). The amino acid analysis of the hydrolyzed sample was performed on a HPLC system (Shimadzu, Japan) equipped with a fluorescence detector (Shimadzu, Japan) and reversed-phase Chromolith Performance RP-18e column, 100 × 4.6 mm (Merck, Germany), using precolumn derivatization with o-phthalaldehyde (OPA) and 3-sulfanylpropanoic acid (excitation at 229 nm, emission at 450 nm) and a gradient elution of 0–100% solvent B over 35 min at a flow rate of 1.0 mL min−1 (solvent A: 0.05 M sodium acetate buffer, pH 6.5; solvent B: 300 mL of 0.17 M sodium acetate and 700 mL of methanol). The amount of pHPMA was calculated according to the calibration of β-alanine, which is present in the hydrolyzed polymer in a known quantity (0.451 mmol g−1 polymer). The amount of antibody was calculated according to the calibration prepared from the free antibody solution hydrolyzed and derivatized using the same protocol as described above.
+ Open protocol
+ Expand
3

Metabolite Extraction and LC/MS Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to the extraction, 200 μM of internal standard ferulic acid or sesamin were added to the samples appointed for quantitative analysis. Metabolites were extracted twice using 1 mL of ethyl acetate, the resulting organic phase was then evaporated under reduced pressure. After evaporation, samples were resuspended in methanol (MeOH, 99.9 % LC/MS grade, Fischer Scientific) for LC/MS analysis.
Both qualitative and quantitative analysis were performed by liquid chromatography coupled with mass spectrometry (LC/MS) measurements on LCMS‐2020 system (Shimadzu, Tokyo, Japan) equipped with a Chromolith® Performance RP‐18e column (100×4.6 mm, Merck). More details are provided in Tables S7 and S8). Samples appointed for quantitative analysis were made in technical and biological duplicate at least.
+ Open protocol
+ Expand
4

HPLC Analysis of Chromatographic Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HPLC analysis was performed with a VWR Hitachi Chromaster 600 chromatograph with a spectrophotometric detector (DAD) on a Chromolith® Performance RP-18e column (100 × 4.6 mm) (Merck, Darmstadt, Germany). The chromatographic parameters were evaluated using EZChrom Elite Software (Merck, Darmstadt, Germany). All chromatographic experiments were replicate tree times. Figures presenting interaction between variables were created using Statistica 10 software (StatSoft, Polska).
+ Open protocol
+ Expand
5

Quantification of Rutin in Leaf Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Leaf tissue (100 mg) was extracted overnight at -20°C with 1.5 mL 100% methanol. Doubly deionized water (100 μL) was mixed with 90 μL extract in a GC-MS vial microinsert. Diluted sample (20 μL) was injected onto an Agilent HPLC-1100 with a flow rate of 1 mL/min of a gradient of 0.05% aqueous trifluoroacetic acid (TFA) and acetonitrile (ACN) through a 100 x 4.6 mm Chromolith Performance RP-18e column, 100 x 4.6 mm (Merck; Darmstadt, Germany). Acetonitrile concentration was increased linearly from 10% to 34% over 8 min, followed by a 2 min column wash with 100% ACN and a 2 min re-equilibration to a 9:1 ratio of 0.05% aqueous TFA:ACN. Rutin was identified by spectral comparison with a commercial standard (Sigma-Aldrich, St. Louis, MO) and quantified by absorbance at 330 nm based on an external standard curve.
+ Open protocol
+ Expand
6

Quantification of Adenosine in Glioblastoma Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
U87MG and PC GSCs were maintained under standard culture conditions (37 °C, 5% CO2) for 4 days. Then, GSCs were washed with PBS 1X two times and incubated in 500 μL of Tyrode’s buffer for 1 h at 37 °C. Later, 200 μL of this incubation medium was mixed with 100 μL of citrate buffer (pH 4). Following derivatization with 2-chloroacetaldehyde (Merck®, Darmstadt, Germany) adenosine levels were determined by HPLC fractionation in a Chromolith Performance RP-18e column (Merck®) and fluorescent detection [19 (link)]. Adenosine concentrations (nM) were normalized to the total protein levels (μg).
+ Open protocol
+ Expand
7

Quantification of Key Compounds in Andrographis Plant Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols
An Agilent HP 1100 system (Waldbronn, Germany) with a 20 µL loop, coupled to a Kontron Ultra-Violet (UV) detector (Zurich, Switzerland) and piloted by EZchrome Elite workstation software was used. LC separation was performed on a Chromolith Performance RP-18e column (100 mm × 4.6 mm ID, 2 µm) provided by Merck (Darmstadt, Germany), with a gradient system containing water as solvent A and Methanol as solvent B, using solvent B from 40% to 51% over 9 min, at 3 mL·min−1. To avoid any peak tailing and samples precipitation, they were injected in a mixture of water:methanol of 80:20. Detection was done by UV at 220 nm, and by ELSD giving the profile shown in Figure 3 where we can see the detection of the three main compounds present in the plant: andrographolide 1, didehydroandrographolide 2 and neoandrographiside 3.
+ Open protocol
+ Expand
8

Stability of Radiolabeled Compound 6

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro stability was examined by incubating [18F]6 (7.4 MBq) in human serum (0.3 mL, Innovative Research Inc., Novi, MI) at 37 °C. After 1, 2, and 4 h, a 50 μL aliquot was analyzed by analytical HPLC using a Chromolith® Performance RP-18e column (4.6 × 100 mm, Merck KGaA) eluted with a gradient of ethanol and sodium acetate buffer (0.05 M, pH 5.5). The percentage of ethanol was kept constant at 5% for the first 5 min with a 0.5 mL/min flow rate, and subsequently increased to 90% over 15 min at a flow rate of 1 mL/min.
The in vivo stability of [18F]6 was investigated after intravenous injection (13.0–16.7 MBq) into BALB/c mice. At 0.5 and 1 h post-injection, blood and urine were collected and the mice were euthanized. Samples were centrifuged at 14,000 rpm for 5 min, and the plasma and urine supernatants were analyzed by HPLC as described above for the in vitro stability studies. For both analyses, the percentage of intact [18F]6 was determined by HPLC peak integration.
+ Open protocol
+ Expand
9

Automated Radiosynthesis of [11C]PiB

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 6-OH-BTA-0 precursor was obtained from either ABX advanced biochemical compounds GTmbH (Radeberg, Germany) or Pharmasynth AS (Tartu, Estonia), standard reagents were obtained from Sigma-Aldrich/Merck, sterile solutions were obtained from either Sygehus Apotek Fyn (Odense, Denmark) or Region Hovedstadens Apotek (Herlev, Denmark), and sterile Cathivex-GV 0.22 µm filters (SLGV0250S) were obtained from Merck Millipore. [11C]CO2 was produced by the bombardment of the target gas, 99.5% N2 + 0.5% O2 (Strandmøllen A/S, Klampenborg, Denmark), using a GE PETtrace cyclotron (Table 3).
The automated [11C]PiB production and product purification processes were performed on a Tracerlab FXc (GE HealthCare, Uppsala, Sweden) fitted with a S1021 HPLC pump (SYKAM, Eresing, Germany), Chromolith Performance RP-18e column (100 × 10 mm, Merck, Soeborg, Denmark), and K-2001 UV detector (Knauer, Berlin, Germany). The radiosynthesis process and semi-preparative HPLC are described further in Section S3 (Supplementary Materials) and Table 2.
+ Open protocol
+ Expand
10

Enantioselective Analysis of Lignans by GC/MS and LC/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
GC/MS analysis was performed as described previously [17 (link)].
Non-chiral LC/MS measurements were performed on a LC/MS-2020 (Shimadzu, Duisburg, Germany) equipped with a Chromolith® Performance RP-18e column (100 × 4.6 mm, Merck, Darmstadt, Germany). A solvent gradient of methanol and 0.1 % formic acid at a flow rate of 0.5 ml min−1 was applied as follows: starting from 20 to 35 % methanol in 5 min, hold for 5 min, increase to 70 % methanol within 15 min, then to 90 % methanol within 1 s, hold for 1 min, re-equilibration with 20 % methanol. UV/Vis spectra were monitored in the range between 190–800 nm. The interface temperature was 350 °C, the desolvation line temperature was 275 °C, and the heat block temperature was 400 °C. The nebulizing gas flow and the drying gas flow were set to 1.5 and 15 l min−1, respectively.
For determination of the enantiomeric composition of pinoresinol 3, lariciresinol 4, and secoisolariciresinol 5 reaction mixtures were analysed by chiral HPLC (Shimadzu, Duisburg, Germany) equipped with a CHIRALPAK®IB column (250 × 4.6 mm, Chiral Technologies Europe, Illkirch Cedex, France). The solvents n-hexane/ethanol were used under isocratic conditions (pinoresinol 3: 50/50; lariciresinol 4: 80/20, secoisolariciresinol 5: 75/25) at a flow rate of 0.7 ml min−1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!